Rautaharju PM, Surawicz B, Gettes LS (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, t and u waves, and the QT interval: A scientific statement from the American heart association electrocardiography and arrhythmias C. https://doi.org/10.1161/CIRCULATIONAHA.108.191096. Circulation 119:
Kallergis EM, Goudis CA, Simantirakis EN et al (2012) Mechanisms, risk factors, and management of acquired long Qt syndrome: a comprehensive review. Sci World J. https://doi.org/10.1100/2012/212178
Tse G, Chan YWF, Keung W, Yan BP (2017) Electrophysiological mechanisms of long and short QT syndromes. IJC Heart & Vasculature 14:8–13. https://doi.org/10.1016/j.ijcha.2016.11.006
Shah RR (2002) The significance of QT interval in drug development. Br J Clin Pharmacol 54:188–202. https://doi.org/10.1046/J.1365-2125.2002.01627.X
Article CAS PubMed PubMed Central Google Scholar
Lin YL, Kung MF (2009) Magnitude of QT prolongation associated with a higher risk of Torsades de pointes. Pharmacoepidemiol Drug Saf 18:235–239. https://doi.org/10.1002/PDS.1707
Article CAS PubMed Google Scholar
Gibbs C, Thalamus J, Kristoffersen DT et al (2019) QT prolongation predicts short-term mortality independent of comorbidity. Europace 21:1254–1260. https://doi.org/10.1093/EUROPACE/EUZ058
Article PubMed PubMed Central Google Scholar
MacNeil DJ, Davies RO, Deitchman D (1993) Clinical safety profile of Sotalol in the treatment of arrhythmias. Am J Cardiol. https://doi.org/10.1016/0002-9149(93)90024-7
Somberg JC, Vinks AA, Dong M, Molnar J (2020) Model-informed development of Sotalol loading and dose escalation employing an intravenous infusion. Cardiol Res 11:294–304. https://doi.org/10.14740/cr1143
Article PubMed PubMed Central Google Scholar
ICH E14 Guideline (2005) Clinical evaluation of QT/QTc interval prolongation and. proarrhythmic potential for non-antiarrhythmic drugs
Gotta V, Cools F, van Ammel K et al (2015) Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships - a PKPD meta-analysis. Br J Pharmacol 172:4364–4379. https://doi.org/10.1111/bph.13218
Article CAS PubMed PubMed Central Google Scholar
Gotta V, Yu Z, Cools F et al (2016) Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongation. Pharmacol Res Perspect 4:e00270. https://doi.org/10.1002/prp2.270
Article CAS PubMed PubMed Central Google Scholar
Chen L, Sampson KJ, Kass RS (2016) Cardiac delayed rectifier potassium channels in health and disease. Card Electrophysiol Clin 8:307. https://doi.org/10.1016/J.CCEP.2016.01.004
Article PubMed PubMed Central Google Scholar
Baracaldo-Santamaría D, Llinás-Caballero K, Corso-Ramirez JM et al (2021) Genetic and molecular aspects of drug-induced QT interval prolongation. Int J Mol Sci. https://doi.org/10.3390/IJMS22158090
Article PubMed PubMed Central Google Scholar
Hoek LJ, Brouwer JLP, Voors AA, Maass AH (2023) Smart devices to measure and monitor QT intervals. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2023.1172666
Article PubMed PubMed Central Google Scholar
Svennberg E, Tjong F, Goette A et al (2022) How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace 24:979–1005. https://doi.org/10.1093/europace/euac038
Article PubMed PubMed Central Google Scholar
Vink AS, Neumann B, Lieve KVV et al (2018) Determination and interpretation of the QT interval: comprehensive analysis of a large cohort of long QT syndrome patients and controls. Circulation 138:2345–2358. https://doi.org/10.1161/CIRCULATIONAHA.118.033943
Ireland RH, Robinson RTCE, Heller SR et al (2000) Measurement of high resolution ECG QT interval during controlled euglycaemia and hypoglycaemia. Physiol Meas 21:295–303. https://doi.org/10.1088/0967-3334/21/2/309
Article CAS PubMed Google Scholar
Committee for Human Medicinal Products, EMA (2020) ICH guideline E14/S7B: clinical and nonclinical evaluation of QT/QTc. Interval Prolongation and Proarrhythmic Potential - questions and answers
Rabkin SW (2015) Nomenclature, categorization and usage of formulae to adjust QT interval for heart rate. World J Cardiol 7:315. https://doi.org/10.4330/wjc.v7.i6.315
Article PubMed PubMed Central Google Scholar
Bazett HC (1920) An analysis of the time-relations of electrocardiograms. Heart 7:353–370
Fridericia LS (1921) Die Systolendauer im Elektrokardiogramm bei Normalem Menschen und bei Herzkranken. Acta Med Scand 54:17–50. https://doi.org/10.1111/j.0954-6820.1920.tb18266.x
Hodges M (1983) Bazett´s QT correction reviewed: evidence that a linear QT correction for heart rate is better. J Am Coll Cardiol 1:694
Sagie A, Larson MG, Goldberg RJ et al (1992) An improved method for adjusting the QT interval for heart rate (the Framingham heart study). Am J Cardiol 70:797–801. https://doi.org/10.1016/0002-9149(92)90562-D
Article CAS PubMed Google Scholar
Rautaharju PM, Zhang ZM (2002) Linearly scaled, rate-invariant normal limits for QT interval: eight decades of incorrect application of power functions. J Cardiovasc Electrophysiol 13:1211–1218. https://doi.org/10.1046/j.1540-8167.2002.01211.x
Aytemir K, Maarouf N, Gallagher MM et al (1999) Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms. Pacing Clin Electrophysiol 22:1397–1401. https://doi.org/10.1111/j.1540-8159.1999.tb00635.x
Article CAS PubMed Google Scholar
Woosley RL, Romero K (2009) Time to replace bazett’s QT-correction. Pacing Clin Electrophysiol 32:1379–1380. https://doi.org/10.1111/j.1540-8159.2009.02513.x
Benatar A, Decraene T (2001) Comparison of formulae for heart rate correction of QT interval in exercise ECGS from healthy children. Heart 86:199–202. https://doi.org/10.1136/heart.86.2.199
Article CAS PubMed PubMed Central Google Scholar
Rabkin SW, Cheng XB (2016) Newer QT correction formulae to correct QT for heart rate changes during exercise. Am J Med Sci 351:133–139. https://doi.org/10.1016/j.amjms.2015.11.007
Othong R, Wattanasansomboon S, Kruutsaha T et al (2019) Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes. Clin Toxicol 57:234–239. https://doi.org/10.1080/15563650.2018.1510501
Garnett C, Bonate PL, Dang Q et al (2018) Scientific white paper on concentration-QTc modeling. J Pharmacokinet Pharmacodyn 45:383–397. https://doi.org/10.1007/s10928-017-9558-5
Article CAS PubMed Google Scholar
Garnett CE, Zhu H, Malik M et al (2012) Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects. Am Heart J 163:912–930. https://doi.org/10.1016/j.ahj.2012.02.023
Pærregaard MM, Hvidemose SO, Pihl C et al (2021) Defining the normal QT interval in newborns: the natural history and reference values for the first 4 weeks of life. Europace 23:278–286. https://doi.org/10.1093/europace/euaa143
Bratincsák A, Kimata C, Limm-Chan BN et al (2020) Electrocardiogram standards for children and young adults using Z -scores. Circulation: Arrhythmia and Electrophysiology 13:E008253. https://doi.org/10.1161/CIRCEP.119.008253
Rijnbeek PR, Witsenburg M, Schrama E et al (2001) New normal limits for the paediatric electrocardiogram. Eur Heart J 22:702–711. https://doi.org/10.1053/EUHJ.2000.2399
Comments (0)